Sangamo-Therapeutics on Bioeconhttps://en.bioecon.ru/companies/sangamo-therapeutics/Recent content in Sangamo-Therapeutics on BioeconHugoen-USFri, 03 Jul 2026 21:49:31 +0700Epigenome editinghttps://en.bioecon.ru/technology/epigenome-editing/Fri, 03 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/epigenome-editing/Turning genes on or off by rewriting DNA methylation and histone marks with dCas9 fusion proteins or zinc fingers — no DNA sequence change, but an effect that can be inherited across cell divisions.